Product familiarisation programs

Product familiarisation programs (sometimes also called ‘patient familiarisation programs’) are provided by pharmaceutical companies and are designed to familiarise prescribers with a newly approved medicine while Pharmaceutical Benefits Scheme (PBS) listing is pending.1 They are usually targeted at...

Full description

Saved in:
Bibliographic Details
Published in:Australian prescriber 2017-12, Vol.40 (6), p.206-207
Main Author: Kyle, Greg
Format: Article
Language:English
Subjects:
Anticoagulants
Corporate sponsorship
Decision making
Patients
Pharmaceutical industry
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Product familiarisation programs (sometimes also called ‘patient familiarisation programs’) are provided by pharmaceutical companies and are designed to familiarise prescribers with a newly approved medicine while Pharmaceutical Benefits Scheme (PBS) listing is pending.1 They are usually targeted at specialists and, according to Medicine Australia’s Code of Conduct, each individual prescriber can only enrol up to ten patients in a program. [...]use allows specialists and GPs to test and monitor patients enrolled in the program, thereby increasing their experience with the new drug and enabling earlier reporting of any adverse drug reactions in ‘real world’ as opposed to clinical trial patients. Another advantage is cost. Because the drug’s sponsor bears the cost of the product supplied during the program, treatment is free for the patient.
ISSN:0312-8008
1839-3942
DOI:10.18773/austprescr.2017.076